This disparity between obese and lean patients to develop obesity-associated diseases upon inhalation of air pollutants can be prevented by blocking free radical processes in the obese lung with specific antioxidants that target MPO or MPO-derived oxidants, such as HOCl (Figure 2). The gene discussed is MPO; the disease is obesity due to melanocortin 4 receptor deficiency.